Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ruigang Diao"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background The sharp increase in fungal infections, insufficient diagnostic and treatment capabilities for fungal infections, poor prognosis of patients with fungal infections as well as the increasing drug resistance of fungi are serious cl
Externí odkaz:
https://doaj.org/article/07277bda72c64db8b75f6e76dd456489
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundRecently, a sum of trials of programmed cell death-1 (PD-1) inhibitors combined with chemotherapy have shown excellent efficacy compared to chemotherapy alone in patients with previously untreated, advanced esophageal squamous cell carcinom
Externí odkaz:
https://doaj.org/article/850822955b224e7dbafb236b943d88d3
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201993 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0182908.].
Externí odkaz:
https://doaj.org/article/4d1d09b5b547466489f999f2abd59143
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182908 (2017)
The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better prognosis. In our work, by utilizing the expression
Externí odkaz:
https://doaj.org/article/94c63ecc60cd4eca8bae359cff804362
Publikováno v:
Oncotarget
Bladder cancer (BLCA) is one of the most malignant cancers worldwide, and its prognosis varies. 1214 BLCA samples in five different datasets and 2 platforms were enrolled in this study. By utilizing the gene expression in The Cancer Genome Atlas (TCG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cacf0e39d8278158b49e835b268a4a80
https://doi.org/10.18632/oncotarget.18642
https://doi.org/10.18632/oncotarget.18642
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182908 (2017)
PLoS ONE
PLoS ONE
The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better prognosis. In our work, by utilizing the expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbeca79e141dce7bc6c3609d63feb12f
https://doi.org/10.1371/journal.pone.0182908
https://doi.org/10.1371/journal.pone.0182908